However, while the sample size is small, this is the first study demonstrating for the first time that it is the elevated peripheral concentration of IL-6 (rather than of other pro-inflammatory cytokines) that clinically affects cognition and mechanistically affects neurogenesis in the same COVID-19 patients with delirium. The gene discussed is IL6; the disease is COVID-19.